ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

House Republicans Move To Slash NIH Spending As Obama Calls For Renewed Investment in Science

February 18, 2011

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013